These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9016896)

  • 61. Improved immunogenicity of a novel third-generation recombinant hepatitis B vaccine in patients with end-stage renal disease.
    Weinstein T; Chagnac A; Boaz M; Ori Y; Herman M; Zevin D; Schmilovitz-Weiss H; Gafter U
    Nephron Clin Pract; 2004; 97(2):c67-72. PubMed ID: 15218332
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term protection after hepatitis B vaccination in people living with HIV.
    Lara AN; Sartori AM; Fonseca MO; Lopes MH
    Vaccine; 2017 Jul; 35(33):4155-4161. PubMed ID: 28669615
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hepatitis B vaccination: addressing a drug-related problem in hemodialysis outpatients with a collaborative initiative.
    Elwell RJ; Neumann M; Manley HJ; Carpentier L; Bailie GR
    Nephrol Nurs J; 2003 Jun; 30(3):310-3. PubMed ID: 12861899
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Association of humans leucocitary antigens with humoral nonresponsive to hepatitis B vaccine in chronic hemodialysis patients].
    de Sousa Júnior JX; de Monte Neto JT; de Castro JA; de Andrade HM; do Monte SJ
    Rev Soc Bras Med Trop; 2004; 37(1):15-7. PubMed ID: 15042175
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anti-HBs antibody persistence following primary vaccination with an investigational AS02(v)-adjuvanted hepatitis B vaccine in patients with renal insufficiency.
    Surquin M; Tielemans C; Nortier J; Jadoul M; Peeters P; Ryba M; Roznovsky L; Domán J; Barthelemy X; Crasta PD; Messier M; Houard S
    Hum Vaccin; 2011 Sep; 7(9):913-8. PubMed ID: 21892006
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Recombinant Hepatitis B Vaccine Adjuvanted With AS04 in Dialysis Patients: A Prospective Cohort Study.
    Fabrizi F; Tarantino A; Castelnovo C; Martin P; Messa P
    Kidney Blood Press Res; 2015; 40(6):584-92. PubMed ID: 26566033
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevalence of non-responsiveness to an indigenous recombinant hepatitis B vaccine: a study among South Indian health care workers in a tertiary hospital.
    Thomas RJ; Fletcher GJ; Kirupakaran H; Chacko MP; Thenmozhi S; Eapen CE; Chandy G; Abraham P
    Indian J Med Microbiol; 2015 Feb; 33 Suppl():32-6. PubMed ID: 25657153
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Persistence of immune memory to hepatitis B vaccine among infants with normal or high antibody response to primary vaccination: a five-year following-up study].
    Zhang L; Yan B; Liu J; Lyu J; Feng Y; Xu A; Song L; Liang X; Li L; Cui F; Zhang G; Wang F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1372-6. PubMed ID: 26850392
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysis.
    Van Der Meeren O; Crasta P; Cheuvart B; De Ridder M
    Hum Vaccin Immunother; 2015; 11(7):1726-9. PubMed ID: 25996260
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Peritoneal dialysis is the better therapy choice for successful anti-hepatitis B vaccination.
    Svác J; Skladaný L; Sekerková Z; Javorský P; Leskova L; Mizla P; Jankechová I; Pasminka T
    Adv Perit Dial; 2005; 21():151-3. PubMed ID: 16686308
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-term evaluation of the hepatitis B vaccine (Heptavax-B) in hemodialysis patients.
    Pasko MT; Bartholomew WR; Beam TR; Amsterdam D; Cunningham EE
    Am J Kidney Dis; 1988 Apr; 11(4):326-31. PubMed ID: 2965511
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A randomised controlled trial of intradermal hepatitis B vaccination and augmentation of response with erythropoietin.
    Anandh U; Thomas PP; Shastry JC; Jacob CK
    J Assoc Physicians India; 2000 Nov; 48(11):1061-3. PubMed ID: 11310381
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
    Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R
    Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of high-flux hemodialysis on delayed hepatitis B virus vaccination response in hemodialysis patients.
    He Q; Wu F; Zhang P; Chen J
    Postgrad Med; 2011 May; 123(3):150-2. PubMed ID: 21566425
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunogenicity of Augmented Compared With Standard Dose Hepatitis B Vaccine in Pediatric Patients on Dialysis: a Midwest Pediatric Nephrology Consortium Study.
    Misurac JM; VanDeVoorde RG; Kallash M; Iorember FM; Luckritz KE; Rheault MN; Jetton JG; Turman MA; Kapur G; Twombley KE; Hashmat S; Weaver DJ; Leiser JD; Nailescu C
    Clin J Am Soc Nephrol; 2017 May; 12(5):772-778. PubMed ID: 28270432
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of interferon λ3 gene polymorphisms, rs8099917 and rs12979860, on response to hepatitis B virus vaccination and hepatitis B or C virus infections among hemodialysis patients.
    Grzegorzewska AE; Jodłowska E; Mostowska A; Jagodziński P
    Pol Arch Med Wewn; 2015; 125(12):894-902. PubMed ID: 26658164
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial.
    Feng Y; Shi X; Shi J; Gao L; Liu G; Cheng Y; Pan M; Li C; Wang J; Guo X; Zhang Y; Liang X; Wang S
    Expert Rev Vaccines; 2017 Oct; 16(10):1045-1052. PubMed ID: 28803502
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Low dose intradermal versus high dose intramuscular hepatitis B vaccination in patients on chronic hemodialysis.
    Roozbeh J; Moini M; Lankarani KB; Sagheb MM; Shahpoori S; Bastani B
    ASAIO J; 2005; 51(3):242-5. PubMed ID: 15968954
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Modulation of the immune response to HBV vaccination by hemodialysis membranes.
    Dede F; Yıldız A; Aylı D; Colak N; Odabaş AR; Akoğlu H; Eskioğlu E; Covic A
    Int Urol Nephrol; 2010 Dec; 42(4):1069-75. PubMed ID: 19618288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.